Skip to main content
Fig. 5 | Journal for ImmunoTherapy of Cancer

Fig. 5

From: CD45RA+CCR7 CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab

Fig. 5

Patients with PR display reduced frequencies of CD8 T cells co-expressing CD28 and CD40L or CD28 and ICOS. (a) Density plots of all data points (ALL: cells from 71 patients, 3 time points each) and split up according to BOR and time points. Plot with 8 clusters (lower left) is the result of gradients of density plots and iterative testing (see Materials and Methods for details). Individual clusters were assessed for significant differences between BOR groups and time points, and highlighted by red lines (see also Additional file 1: Figure S3D). (b) Density plots of individual markers and (c) expressions of markers within individual clusters according to relative intensities; clusters showing different abundance (from panel A) are highlighted by red rectangles. (d) Sum of different types of co-stimulatory receptors that are expressed by CD8 T cells at baseline. Orange circles visualize fraction of CD8 T cells expressing 0 or 1 type of co-stimulatory receptors. (e) Frequencies of CD8 T cells positive for single markers or combinations of two markers with significant differences. Markers used are listed in Additional file 1: Table S2, panel 5. Statistically significant differences between BOR groups and time points were determined using Mann–Whitney U test. * p < 0.05

Back to article page